Bio-Rad Laboratories (BIO) Earnings Date, Estimates & Call Transcripts → Democrats’ “break glass for emergency” candidate for 2024 (From The Freeport Society) (Ad) Free BIO Stock Alerts $281.73 -1.56 (-0.55%) (As of 06/13/2024 ET) Add Compare Share Share EarningsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends Earnings SummaryUpcoming Earnings DateAug. 1EstimatedActual EPS (May. 7) $2.29 Beat By $0.25 Consensus EPS (May. 7) $2.04 Read Call TranscriptListen to Call Get Bio-Rad Laboratories Earnings AlertsEnter your email address below to receive the latest news and earnings results for BIO and its competitors with MarketBeat's FREE daily newsletter. Skip Charts & View Estimated and Actual Earnings DataEarnings Per ShareRevenueBIO Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.BIO Estimated and Actual Revenue by Quarter Estimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. Ad The Freeport SocietyDemocrats’ “break glass for emergency” candidate for 2024Nate Silver has been a celebrity pundit since at least the 2008 election, when he correctly predicted the winner in 49 of 50 states, and nailed all 35 Senate election outcomes. But interestingly, one man reached the same conclusion as Nate Silver a long time ago…For full details, click here. Bio-Rad Laboratories Analyst EPS EstimatesQuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateCompany GuidanceQ1 20241$2.06$2.06$2.06 Q2 20241$2.03$2.03$2.03 Q3 20241$2.70$2.70$2.70 Q4 20241$3.39$3.39$3.39 FY 20244$10.18$10.18$10.18 Q1 20251$2.40$2.40$2.40 Q2 20251$2.63$2.63$2.63 Q3 20251$3.44$3.44$3.44 Q4 20251$2.99$2.99$2.99 FY 20254$11.46$11.46$11.46 Q1 20261$3.18$3.18$3.18 BIO Earnings Date and InformationBio-Rad Laboratories last posted its earnings results on May 7th, 2024. The medical research company reported $2.29 EPS for the quarter, beating the consensus estimate of $2.04 by $0.25. The business earned $610.82 million during the quarter, compared to analysts' expectations of $619.09 million. Its revenue for the quarter was down 9.8% on a year-over-year basis. Bio-Rad Laboratories has generated ($10.36) earnings per share over the last year (($10.36) diluted earnings per share). Earnings for Bio-Rad Laboratories are expected to grow by 8.80% in the coming year, from $10.80 to $11.75 per share. Bio-Rad Laboratories has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, August 1st, 2024 based off prior year's report dates.Read More Bio-Rad Laboratories Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years 10 Years Time Frame * Start Date * End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript 8/1/2024(Estimated)------- 5/7/2024Q1 2024$2.04$2.29+$0.25($8.87)$619.09 million$610.82 million 2/15/2024Q4 2023$2.93$3.10+$0.17($5.94)$685.00 million$681.18 million 10/26/2023Q3 2023$2.87$2.33($0.54)$1.02$689.50 million$632.10 million 8/3/2023Q2 2023$2.55$3.00+$0.45$45.59$697.96 million$681.10 million 5/4/2023Q1 2023$3.24$3.34+$0.10$4.36$689.28 million$676.80 million 2/16/2023Q4 2022$3.45$3.31($0.14)($21.16)$741.01 million$730.29 million Get the Latest News and Ratings for BIO and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Bio-Rad Laboratories and its competitors with MarketBeat's FREE daily newsletter. 10/27/2022Q3 2022$2.59$2.60+$0.01$10.72$685.50 million$680.10 million 7/28/2022Q2 2022$2.46$3.38+$0.92$37.88$664.60 million$691.10 million 4/28/2022Q1 2022$2.80$4.94+$2.14$122.45$678.00 million$700.10 million 2/10/2022Q4 2021$2.87$3.21+$0.34$59.01$731.94 million$732.80 million 10/28/2021Q3 2021$2.30$3.71+$1.41($122.54)$670.36 million$747.00 million 7/28/2021Q2 2021$2.66$3.54+$0.88($23.24)$610.40 million$715.93 million 4/29/2021Q1 2021$2.50$5.21+$2.71($21.96)$661.00 million$726.80 million 2/10/2021Q4 2020$3.30$4.01+$0.71($19.79)$681.80 million$789.84 million 10/29/2020Q3 2020$1.85$3.00+$1.15($37.64)$567.35 million$647.26 million 7/30/2020Q2 2020$1.22$1.61+$0.39($28.93)$526.80 million$536.88 million 5/6/2020Q1 2020$1.57$1.91+$0.34($18.90)$545.70 million$571.60 million 2/13/2020Q4 2019$2.44$2.32($0.12)($13.67)$636.50 million$624.43 million 10/31/2019Q3$1.36$1.61+$0.25$11.90$561.40 million$560.60 million 8/1/2019Q2 2019$1.39$1.57+$0.18($16.72)$564.88 million$572.60 million Bio-Rad Laboratories Earnings - Frequently Asked Questions When is Bio-Rad Laboratories's earnings date? Bio-Rad Laboratories has not confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, August 1st, 2024 based off last year's report dates. Learn more on BIO's earnings history. Did Bio-Rad Laboratories beat their earnings estimates last quarter? In the previous quarter, Bio-Rad Laboratories (NYSE:BIO) reported $2.29 earnings per share (EPS) to beat the analysts' consensus estimate of $2.04 by $0.25. Learn more on analysts' earnings estimate vs. BIO's actual earnings. How can I listen to Bio-Rad Laboratories's earnings conference call? The conference call for Bio-Rad Laboratories's latest earnings report can be listened to online. Listen to Conference Call How can I read Bio-Rad Laboratories's conference call transcript? The conference call transcript for Bio-Rad Laboratories's latest earnings report can be read online. Read Transcript How much revenue does Bio-Rad Laboratories generate each year? Bio-Rad Laboratories (NYSE:BIO) has a recorded annual revenue of $2.67 billion. How much profit does Bio-Rad Laboratories generate each year? Bio-Rad Laboratories (NYSE:BIO) has a recorded net income of -$637.32 million. BIO has generated -$10.36 earnings per share over the last four quarters. What is Bio-Rad Laboratories's EPS forecast for next year? Bio-Rad Laboratories's earnings are expected to grow from $10.80 per share to $11.75 per share in the next year, which is a 8.80% increase. More Earnings Resources from MarketBeat Related Companies: MTD Earnings ILMN Earnings WAT Earnings TECH Earnings CRL Earnings BRKR Earnings PACB Earnings LIFE Earnings HBIO Earnings TMO Earnings Earnings Tools: Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country: U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Australia Earnings Reports Latest Articles: Apple Stock All-Time Highs: Can AI Outweigh Earnings Jitters?CrowdStrike's Earnings: Consolidation and AI-Driven Growth The Most Upgraded Stocks After the Q1 Earnings Season ZIM Shipping Stock Forecast, Earnings Triggers a BuyAmerican Superconductor's Earnings Surge, Future Growth ExpectedHormel: A Potential Buy Despite Post-Earnings DeclineCanopy Growth’s Earnings: Profitability Despite Industry Shifts This page (NYSE:BIO) was last updated on 6/14/2024 by MarketBeat.com Staff From Our PartnersA once-in-a-century investment opportunityIt's an under-the-radar stock reshaping a projected $109 billion industry - And, I believe, has far more poten...Stansberry Research | SponsoredNvidia is Pivoting to Solve Big Tech’s $1 Trillion ProblemTaiwan Semiconductor, a partner of Nvidia’s for more than two decades, has seen its shares explode as much as ...Weiss Ratings | SponsoredJeff Bezos & 48 Members of Congress Are Buying ONE Sector…Why are Warren Buffett, Jeff Bezos, Michael Bloomberg, “The Walmart Family”, Bill Gates, and 48 members of Con...InvestorPlace | SponsoredMy 3 Top CryptocurrenciesMore than a decade after the first Bitcoin was mined, people are finally realizing something very important......Manward Press | SponsoredAn utter travestyThe 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | SponsoredEstee Lauder, MAC, and other beauty brands are raving about this emerging NYSE AI companyA Little-known NYSE Company is Empowering the Beauty Industry with Innovative AI and AR Tools.Financial Markets Daily | SponsoredMoonshot Coins for the Current Crypto RunAre you monitoring 13,217 cryptocurrencies everyday? If not, you could miss the ONE that can make you wealt...Crypto 101 Media | SponsoredMan who Predicted Trump 2016 Win: “Prepare for Election Meltdown”Former advisor to the CIA, the Pentagon and the White House Jim Rickards went on multiple TV news programs… ...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Bio-Rad Laboratories, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Bio-Rad Laboratories With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.